Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Barbara Ann Karmanos Cancer Institute Identifier:
First received: November 1, 1999
Last updated: April 3, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2003
  Primary Completion Date: July 1999 (Final data collection date for primary outcome measure)